De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Eurazeo Beheer

Beheer criteriumcontroles 2/4

De CEO Eurazeo's is Christophe Baviere, benoemd in Mar2021, heeft een ambtstermijn van 3.58 jaar. bezit rechtstreeks 0.22% van de aandelen van het bedrijf, ter waarde € 11.63M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.6 jaar en 10.4 jaar.

Belangrijke informatie

Christophe Baviere

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	3.6yrs
Eigendom CEO	0.2%
Management gemiddelde ambtstermijn	2.6yrs
Gemiddelde ambtstermijn bestuur	10.4yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Christophe Baviere's beloning veranderd ten opzichte van Eurazeo's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	-€77m
Mar 31 2024	n/a	n/a	€873m
Dec 31 2023	n/a	n/a	€2b
Sep 30 2023	n/a	n/a	€2b
Jun 30 2023	n/a	n/a	€2b
Mar 31 2023	n/a	n/a	€2b
Dec 31 2022	€2m	€555k	€595m
Sep 30 2022	n/a	n/a	€801m
Jun 30 2022	n/a	n/a	€1b
Mar 31 2022	n/a	n/a	€1b
Dec 31 2021	€1m	€487k	€2b

Compensatie versus markt: Er zijn onvoldoende gegevens om vast te stellen of de totale vergoeding van Christophe redelijk is in vergelijking met bedrijven van vergelijkbare omvang in de German markt.

Compensatie versus inkomsten: De vergoeding van Christophe is gestegen terwijl het bedrijf verliesgevend is.

CEO

Christophe Baviere (60 yo)

3.6yrs

Tenure

€1,791,427

Compensatie

Mr. Christophe M. Baviere serves as Co-Chief Executive Officer at Eurazeo North America, Inc since February 2023. He is Co-Chairman of the Executive Board & Co-CEO of Eurazeo SE from 2023. He was Chairman...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Christophe Baviere	Co-CEO & Co-Chairman of the Executive Board	3.6yrs	€1.79m	0.22% € 11.9m
William Kadouch-Chassaing	Co-CEO & Co-Chairman of Executive Board	2.6yrs	€1.68m	geen gegevens
Olivier Millet	Member of the Executive Board and Managing Partner of Small-mid buyout & NovSanté	6.6yrs	€1.62m	0.071% € 3.8m
Laurence Branthomme	CFO & Head of Operations	1.8yrs	geen gegevens	geen gegevens
Sophie Flak	Member of Executive Board	1.7yrs	geen gegevens	0.015% € 794.7k
Arnaud Berthe	Managing Director of Group Accounting	no data	geen gegevens	geen gegevens
Valérie Ducourty	Managing Director of Corporate Financing	no data	geen gegevens	geen gegevens
Jean-Daniel Vouille	Chief Technical Officer	no data	geen gegevens	geen gegevens
Domitille Doat-Le Bigot	Chief Digital & Information Officer	less than a year	geen gegevens	geen gegevens
Pierre Bernardin	Director & Head of Investor Relations	5.1yrs	geen gegevens	geen gegevens
Sylviane Guyonnet	Deputy CEO of EGI & Group Head of Compliance	no data	geen gegevens	geen gegevens
Florine Letort	Legal & Compliance Manager	no data	geen gegevens	geen gegevens

2.6yrs

Gemiddelde duur

53.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van EUQ wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.6 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Vivianne Akriche	Employee Representative Member of the Supervisory Board & Managing Director of Mid-large buyout	5.7yrs	geen gegevens	0.016% € 874.0k
Stephane Bostyn	Employee Representative Supervisory Board Member	no data	geen gegevens	0.0074% € 397.1k
Bruno Roger	Honorary Chairman of the Supervisory Board	no data	€145.71k	geen gegevens
Jean-Pierre Richardson	Non-Voting Board Member	16.4yrs	€66.14k	0.0023% € 125.7k
Jean-Charles Decaux	Chairman of the Supervisory Board	7.3yrs	€193.33k	0.0011% € 61.5k
Victoire de Margerie	Independent Member of Supervisory Board	12.4yrs	€47.00k	0.0011% € 59.9k
Stephane Pallez	Independent Member of the Supervisory Board	11.4yrs	€78.25k	0.0023% € 124.6k
Olivier du Vignaux	Vice Chairman of Supervisory Board	20.4yrs	€103.00k	0.0012% € 64.7k
Roland du de Montsaulnin	Member of Supervisory Board	20.4yrs	€55.00k	0.0029% € 157.0k
Francoise Mercadal-Delasalles	Independent Member of the Supervisory Board	9.4yrs	€102.00k	0.0011% € 58.8k
Mathilde Lemoine	Independent Member of the Supervisory Board	2.5yrs	€32.00k	0.00035% € 18.9k
Emmanuel Russel	Member of Supervisory Board	7.3yrs	€103.14k	geen gegevens

10.4yrs

Gemiddelde duur

62yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van EUQ zijn ervaren en ervaren (gemiddelde ambtstermijn van 10.4 jaar).

Eurazeo Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Cathia Lawson-Hall Joins the Board of Eurazeo SE as Non-Executive Director

Eurazeo SE, Annual General Meeting, May 07, 2025

Eurazeo SE, Annual General Meeting, May 07, 2024

Eurazeo SE, Annual General Meeting, Apr 28, 2022

Eurazeo Appoints Christophe Bavière as Head of Investment Partners

Eurazeo Appoints Sophie Flak to Its Executive Committee

Recent updates

Eurazeo SE (ENXTPA:RF) and management of Eres acquired an unknown majority stake in Eres Gestion from IK VIII, a fund managed by IK Partners.

First half 2024 earnings released: €1.43 loss per share (vs €25.36 profit in 1H 2023)

Eurazeo SE (ENXTPA:RF) and Marlin Equity Partners, LLC agreed to acquire an unknown majority stake in Rydoo N.V. from Marlin Equity Partners, LLC.

Bridgepoint Europe VII fund managed by Bridgepoint Group plc (LSE:BPT) signed an agreement to acquire unknown majority stake in LumApps SAS from a group of shareholders for $650 million.

Cathia Lawson-Hall Joins the Board of Eurazeo SE as Non-Executive Director

Eurazeo SE, Annual General Meeting, May 07, 2025

Upcoming dividend of €2.42 per share

Eurazeo SE (ENXTPA:RF) and management of Eres signed an agreement to acquire an unknown majority stake in Eres Gestion from IK VIII, a fund managed by IK Partners on April 22, 2024.

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: €25.94 (vs €8.33 in FY 2022)

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €200 million worth of its shares.

Eurazeo SE, Annual General Meeting, May 07, 2024

Eurazeo SE (ENXTPA:RF) acquired 34% stake in BMS Group Limited from Bms Investment Holdings Limited.

Eurazeo SE to Report Fiscal Year 2023 Results on Mar 07, 2024

New major risk - Revenue and earnings growth

Eurazeo SE to Report First Half, 2023 Results on Jul 27, 2023

Upcoming dividend of €2.20 per share at 3.3% yield

Full year 2022 earnings released: EPS: €8.33 (vs €22.17 in FY 2021)

Eurazeo SE (ENXTPA:RF) alongside NeoXam's founder Serge Delpla and its management team led by Florent Fabre intered into an agreement to acquire NeoXam from Bpifrance Investissement SAS and Cathay Capital Private Equity SAS.

An investor group led by North Castle Partners, LLC has reached an agreement to acquire an unknown majority stake in Nest New York from Eurazeo SE (ENXTPA:RF).

carsales.com Ltd (ASX:CAR) completed the acquisition of remaining 51% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Macquarie Group Limited (ASX:MQG) in a consortium with British Columbia Investment Management Corporation and MEAG MUNICH ERGO Asset Management GmbH acquired Reden Solar for an enterprise value of €2.5 billion.

Eurazeo SE (ENXTPA:RF) alongside the WiiSmile's management team entered into agreement to acquire majority stake in WiiSmile SA.

Eurazeo SE to Report First Half, 2022 Results on Jul 27, 2022

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €100 million worth of its shares.

Upcoming dividend of €3.00 per share

Eurazeo SE, Annual General Meeting, Apr 28, 2022

Investor sentiment improved over the past week

Eurazeo European Real Estate II, managed by Eurazeo SE (ENXTPA:RF) acquired Six mixed-use commercial properties from Gewerbesiedlungs-Gesellschaft Mit Beschränkter Haftung.

Eurazeo SE (ENXTPA:RF) and existing management team of Cranial Technologies, Inc. signed a definitive agreement to acquire Cranial Technologies, Inc. from BPOC and existing management team.

Eurazeo SE (ENXTPA:RF) agreed to acquire Five Ayre brand hotels from El Corte Inglés, S.A. and Palladium Hotel Group.

Eurazeo SE (ENXTPA:RF) acquire 80% stake in Ikaros Solar NV from its founders and FCPR Capenergie 2, fund managed by Omnes Capital S.A.S.

Eurazeo SE (ENXTPA:RF), Cherng Family Trust and Cohesive Capital Management, L.P. acquired a controlling stake in Beekman 1802 LLC for $92 million.

Safran Enters into Exclusive Discussions to Acquire Orolia

Safran Enters Exclusive Talks to Buy Navigation Technology Company

Eurazeo SE (ENXTPA:RF) along with Arax Properties Ltd entered into an agreement to acquire Trinity Trading Estate in Sittingbourne from St. James's Place plc (LSE:STJ).

carsales.com Ltd (ASX:CAR) completed the acquisition of a 49% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Eurazeo in Talks over Sale of Its Stake in Seqens

Montagu Private Equity LLP agreed to acquire unknown majority stake in In'Tech Medical SAS from Eurazeo SE (ENXTPA:RF).

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Tink AB from SEB Venture Capital, PostePay SpA and others for €1.7 billion.

Eurazeo and Infravia Reportedly to Launch an Auction for Reden

Eurazeo SE (ENXTPA:RF), Theodore-Michel Vrangos and Laurent Charvériat entered into an agreement to acquire 49% stake in I-Tracing SAS from Keensight Capital for €165 million.

Upcoming dividend of €1.50 per share

Full year 2020 earnings released: €2.26 loss per share (vs €1.59 profit in FY 2019)

Eurazeo SE Announces Its Intention to Resume Distribution

Eurazeo SE to Report Fiscal Year 2020 Results on Mar 11, 2021

New 90-day high: €62.80

IK Investment Partners and Luxempart S.A. (BDL:LXMPR) agreed to acquire 20% stake in iM Global Partner from Eurazeo SE (ENXTPA:RF) for €70 million.

AppLovin Corporation entered into a definitive agreement to acquire adjust GmbH.

New 90-day high: €59.80

New 90-day high: €56.85

Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF), IK Investment Partners Fund IX managed by IK Investment Partners and the management team completed the acquisition of an unknown majority stake in QUESTEL SAS from IK VIII, a fund of IK Investment Partners and Raise Investissement, SAS.

New 90-day high: €55.90

Croda International Plc (LSE:CRDA) completed the acquisition of Iberchem S.A. from Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF) and others.

Croda International Plc (LSE:CRDA) agreed to acquire Iberchem S.A. from Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF) and others for €820 million.

New 90-day high: €49.82

New 90-day low: €42.94

Hippocrates Holding Draws Up Shortlist of Four for Italy Pharmacy Network

Eurazeo Seeks to Buy Questel

Eurazeo Appoints Christophe Bavière as Head of Investment Partners

Volkswagen AG has entered into an agreement to sell Europcar International SA to Eurazeo SA for €3.32 billion.

Eurazeo Appoints Sophie Flak to Its Executive Committee

Eurazeo Reportedly in Negotiations to Take Majority Stake in EasyVista

Eurazeo SE (ENXTPA:RF) entered into an agreement to acquire of remaining 20% stake in Idinvest Partners SA from Christophe Bavière, Benoist Grossmann and their partners.

Eurazeo SE (ENXTPA:RF) completed the acquisition of 25% stake in MCH.